#MRNA just lit up with a $1.23M $205 2026-10-16 put at 7.5x OI.
↘️ Options: 100% puts, $1.23M premium
↘️ Dark pool: $177.94M, Sell +33%
➡️ Level: 198.92 resistance
@insiderfinance.com
@insiderfinance.com#MRNA just lit up with a $1.23M $205 2026-10-16 put at 7.5x OI.
↘️ Options: 100% puts, $1.23M premium
↘️ Dark pool: $177.94M, Sell +33%
➡️ Level: 198.92 resistance
@stockmaster70.bsky.social
@wtfwire.bsky.socialThe first mRNA flu vaccine, mFlusiva, is now available for adults 50 and older at over 13,000 US locations, Moderna says.
#WTFWire #mFlusiva #mRNA #FluVaccine #Moderna #PublicHealth #Vaccination #FluSeason #Healthcare #Immunization
@patientmakt.bsky.social
@patientmakt.bsky.social
@pharmalot.bsky.social
@sorenhough.bsky.social@insiderfinance.comInsiderFinance's AI analysis flagged #MRNA at 175.71, and it ran +18.89% to 208.90 in 9 trading days.
↗️ Premium: $73.7M calls vs $39.1M puts
↗️ Fresh flow: $195 calls traded 4,610 vs 184 OI
➡️ Level: $190-$200 into next week
@talesofmanythings.bsky.socialWe can edit DNA.
We can manufacture RNA.
But I didn’t perfect the immortality serum in my garage.
Breaking biological limits isn’t defeating death.
It’s moving the boundary from “impossible” to “not yet”.
wp.me/pgsIo5-iV
#Longevity #Biotech #Science #Medicine #mRNA #Future #Genetics
@financiernews.bsky.social📈 Moderna Rallies 202% Since August on Cancer Vaccine, Analysts Ask If It's a Sell
MRNA trades at $190.01, up 0.57% today and 515.72% year-to-date, sitting in the 98th percentile of its 52-week range.
@patientmakt.bsky.socialPh D Virologist Masfique Mehedi reported the Covid mRNA and mFlusiva designflaw to the FDA in an attempt to stop the use of these mRNA injections. He will assist in lawsuit when injuries occur.
@mari-19.bsky.social
@quartzmedia.bsky.social@patientmakt.bsky.socialReminder vaxscanner.com #Covid19 #mRNA #MACaddress
Read more: books.brightlearn.ai/The-BlueFang...
StratIQ morning trading brief — Oct 2 🌅
Mixed start to the day.
Top driver: Nasdaq-100 inclusion announced today, effective before the Oct 9 open.
Watching: $MRNA, $GOOGL.
https://stratiqai.app/track-record?src=bluesky
Not financial advice.
@quartzmedia.bsky.social
@genesdev.bsky.socialRESEARCH PAPER: Differential control of both cell cycle-regulated and quantitative histone mRNA expression by Drosophila Mute
By Geisler et al. and Robert Duronio
➡️ https://genesdev.cshlp.org/content/40/19-20/1649.abstract
Mark Geisler
#histone #replication #mRNA #Drosophila
@carlus-2024.bsky.socialOctober 1, 2026
👉 What if a cancer vaccine could be designed for each patient?
🙂 Another encouraging news from Groupe UIG.
Read: lnkd.in/d9RyGiG4
#GroupeUIG #Cancer #Oncology #Immunotherapy #mRNA #PersonalizedMedicine #Biotechnology #Innovation #Health
@insiderfinance.comInsiderFinance's AI analysis featured this exact #MRNA Long Call at $175.71. It ran +18.89% in 6 trading days.
↗️ Options: $226.4M calls vs $45.6M puts, +$180.9M net
↗️ Block: $190 Call 2027-03-19, 1,500 vs 279 OI
➡️ Level: $200; price pushed from $183.49 to $203.46
